Paclitaxel cationic liposomes for injection(CSPC Zhongqi Pharma)
注射用紫杉醇阳离子脂质体（石药集团中奇制药）
Report date: 2026/03/24 20:00:35
Base Information
Drug NamePaclitaxel cationic liposomes for injection(CSPC Zhongqi Pharma)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[4]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesCSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesCSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co Ltd
Inactive CompaniesN/A
Active Indications +[4]
Inactive IndicationsN/A